Accessibility Menu
Strata Critical Medical Stock Quote

Strata Critical Medical (NASDAQ: BLDE)

$4.85
(-2.8%)
-0.14
Price as of October 22, 2025, 12:59 p.m. ET

KEY DATA POINTS

Current Price
$4.84
Daily Change
(-2.8%) $0.14
Day's Range
$4.81 - $5.11
Previous Close
$4.99
Open
$5
Beta
1.46
Volume
405,418
Average Volume
1,164,389
Market Cap
407.7M
Market Cap / Employee
$4.99M
52wk Range
$2.35 - $6.02
Revenue
-
Gross Margin
0.22%
Dividend Yield
N/A
EPS
-$0.24
CAPs Rating
-
Industry
Airlines

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Strata Critical Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
BLDE+34.86%-50.05%-12.96%-49%
S&P+15.06%+95.03%+14.29%+119%

Strata Critical Medical Company Info

Blade Air Mobility, Inc. engages in providing air transportation alternatives through a technology-powered and global air mobility platform. It operates through the Passenger and Medical segments. The Passenger segment includes short distance helicopter and amphibious seaplane flights and non-medical jet charter. The Medical segment is involved in the transportation of human organs for transplant. The company was founded by Robert S. Wiesenthal and Steven Martocci on December 22, 2014 and is headquartered in New York, NY.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$70.80M4.2%
Gross Profit$15.96M7.9%
Gross Margin22.54%0.8%
Market Cap$326.50M21.3%
Market Cap / Employee$1.01M0.0%
Employees32214.6%
Net Income-$3.74M67.0%
EBITDA-$3.18M70.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$60.32M112.6%
Accounts Receivable$28.17M1.6%
Inventory00.0%

Liabilities

Q2 2025YOY Change
Long Term Debt$5.32M-70.2%
Short Term Debt$3.52M-15.1%

Ratios

Q2 2025YOY Change
Return On Assets-7.05%9.3%
Return On Invested Capital-13.22%-2.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$6.94M26.6%
Operating Free Cash Flow-$4.22M-156.6%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book0.991.430.981.4930.89%
Price to Sales0.951.360.871.2913.70%
Price to Tangible Book Value1.301.881.301.9931.29%
Enterprise Value to EBITDA-51.14-31.93-18.06-69.69398.48%
Return on Equity-20.7%-12.0%-11.6%-8.4%-58.22%
Total Debt$23.74M$9.32M$9.07M$8.84M-59.84%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.